Top Markets
#1 Islamic Coin Islamic Coin +154.33%
#2 PulseChain PulseChain +49.10%
#3 BOOK OF MEME BOOK OF MEME +41.79%
#4 DogBull DogBull +34.87%
#5 rsERG rsERG +21.49%
#6 Ergo Ergo +18.86%
#7 Bio Protocol Bio Protocol +17.68%
#8 ORDI ORDI +16.80%
#9 RedStone RedStone +15.29%
#10 Nockchain Nockchain +15.20%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Bio Preventive Medicine Corp. Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp.

6810
Rank in Stocks #27174
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
Share Price
$0.70116857
Market Cap
$34.67M
Change (1 day)
-1.78%
Change (1 year)
-18.30%
Country
TW
Trade Bio Preventive Medicine Corp. (6810)

Category

Healthcare
P/E ratio for Bio Preventive Medicine Corp. (6810)
P/E ratio as of 2026 TTM: 0
According to Bio Preventive Medicine Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Bio Preventive Medicine Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.